Similarly, aberrant expression of MCM2 in human cau cause development of oral cancer [29], BC [30] and GC [31], suggesting that MCM2 is the potential biomarker used to predict the prognosis of certain tumors. This evidence concerns the gene MCM2 and gastric cancer.